🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 98420X202 (prev. 98420X103 )
- Market Cap
- Small Cap
- IPO
- 11/16/2017 · $10.00/share
- Previous Symbol
- ASNS (changed 3/12/2019)
- Previous Name
- Arsanis, Inc.
Business: X4 Pharmaceuticals, Inc. is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and cancer. X4’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance.
Company Contact
- CEO
- Adam Craig
- CFO
- David Kirske
- Headquarters
- 61 North Beacon Street, 4th Floor, Boston, MA 02134
- Phone
- 857-529-8300
- Investor Relations
- Candice Ellis · 857-341-1043 · Candice.Ellis@x4pharma.com